CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- 4 Grant or award Director acquired 4,698 shares (grant or award)
- 4 Shares withheld for taxes President and CEO gave up 38,873 shares (to pay taxes)
- 4 Shares withheld for taxes EVP, CFO and Treasurer gave up 16,906 shares (to pay taxes)
- 4 Exercise or conversion Director acquired 3,800 shares (option exercise)
- 4 Open-market sale Director sold 4,150 shares at $9.02 ($37,435)
- 4 Open-market sale Director sold 10,000 shares at an average $8.22 ($82,208)
- 4 Shares withheld for taxes EVP, Chief Legal Officer gave up 12,713 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes EVP, CCO and CBO gave up 317 shares (to pay taxes)
- 4 Exercise or conversion EVP, CFO and Treasurer acquired 2,367 shares (option exercise)
- 4 Open-market sale Director sold 7,500 shares at $14.09 ($105,675)
- 4 Open-market sale Director sold 7,500 shares at an average $13.72 ($102,881)
- 4 Open-market sale President, R&D sold 13,904 shares at an average $14.47 ($201,164)
- 4 Exercise or conversion Director acquired 6,670 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,670 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,670 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,670 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,670 shares (option exercise)
- 4 Exercise or conversion Director acquired 6,670 shares (option exercise)
Page 4 of 38 · 752 filings